Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer

NCT06086665 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT06086665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06086665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Completed
Start date
December 1, 2019
Completion date
October 31, 2022
Enrollment
850 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epithelial ovarian cancer